SF3A2 and Blackfan-Diamond anemia: In addition, our studies suggest that at least SF3A2, and potentially other regulators such as some implicated mRNA translation factors, may be key disease modifiers that alter the impaired erythropoiesis seen in diseases like MDS or Diamond-Blackfan anemia.